Skip to search.
 TSX Up 0.38% TSX Ventures Down 0.06%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.63 Down 0.02(0.75%) Dec 8, 4:00PM EST
|Pre-Market : 2.63 0.00 (0.00%) 4:39PM EST - Nasdaq Real Time Price
Prev Close:2.65
Open:N/A
Bid:2.01 x 100
Ask:3.00 x 300
1y Target Est:6.20
Beta:1.2431
Earnings Date:Mar 6 - Mar 10 (Est.)
Day's Range:N/A - N/A
52wk Range:1.88 - 4.38
Volume:0
Avg Vol (3m):1,358,410
Market Cap:260.20M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 0.75%260.20M
1 0.00%N/A
AMGNDown 0.42%104.59B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.74
Quarterly EPS Est (Dec-16) :-0.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel and targeted drug candidates in the therapeutic areas of immunology, oncology, and immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback